Proventus Consulting is a strategic consulting company specializing on guiding pharmaceutical and biotechnology companies in oncology.
About
We are accomplished leaders and strategists with a history of delivering excellent global business results in the oncology pharmaceutical and biotechnology industry.
We have built best-in-class global brands with strong brand equity while working at a Fortune 150 pharma company by uncovering and leveraging customer insights and creating winning strategic marketing and life-cycle plans.
We are continuing that work today as consultants.
Work
We specialize and focus on the integration of prescriber, patient and payer insights into the drug development process as early as possible through to commercialization strategy to exceed business goals at launch and beyond.
Why Work with Proventus?
We are passionate about oncology – decades of experience
Experience in creating multi billion-dollar plus oncology brands
We define success as setting a new standard of care for patients
Ability to work with other partner agencies to achieve brand goals
Expertise in developing thought leader endorsement
We want to help companies achieve short-term and sustained success
Capabilities and Competencies
Commercial Strategy
•Opportunity, Threat, Strength and Weakness Identification and Analysis•Customer Identification and Insights•Thought Leader Identification and Engagement•Market Understanding of Environment, Competitors and Opportunity•Market Research & Sales Forecasting•Markets Optimization - US, EU, Japan and China•Brand Building and Planning•Non-proprietary and Brand Name Development•Pricing, Reimbursement and Access Strategy•Customer Solution Identification and Development•Competitive Intelligence and Landscapes•Competitive SimulationProduct Development Strategy•FDA Regulatory Strategy•Lifecycle Optimization•Clinical Research Planning•Product LabelingBusiness Development
•Scientific Technology Identification•Valuation Forecast•Due DiligenceManagement Services
•Board Presentations•Team Leadership & Development•Validation of Company/Product Strategies•Competitive SimulationsWho We Are
Bob Marchesani, President
Accomplished leader and strategist with history of delivering excellent global business results in the oncology biopharmaceutical industry
31 years of experience pharmaceutical industry – 27 in oncology – with a proven track record of success in product development, brand strategy, global marketing, brand positioning and differentiation, and launch strategyGlobal brand leader for ALIMTA (pemetrexed), which achieved peak sales of $2.8 billion, excellent brand equity and became Lilly’s top selling product in 2014Exhibited launch excellence, customer insights and life-cycle management skills as a marketing leader for GEMZAR (gemcitabine) which achieved peak sales of $1.7 billion in 2008Demonstrated strategic product and brand development skills as global brand leader for VERZENIO (abemaciclib) which launched in 2017Member of the Board of Directors of Isofol Medical AB, a NASDAQ-listed pharmaceutical company with a phase III drug in developmentAdjunct professor for Capstone Strategy class for Butler University MBA program, Leadership Coach and Executive Mentor for Lacy School of BusinessMember of ASCO and IASLC, and serves on IASLC’s Membership Committee
Ed McMenamin, Principal Consultant
Recognized expert in pharmaceutical development and marketing who connects commercial and clinical teams to insights and executions that result in successful products
36 years of pharmaceutical industry experience in oncology, cardiovascular disease, critical care and other areas – proven track record of success in new product development, brand strategy and positioning, global and US marketing, cross functional integration and external partnershipsPioneered methodology for drug development that enhances product value or drives go/no-go decisions. Utilized as commercial lead on over 50 potential new products including VERZENIO (abemaciclib) launched in 2017Demonstrated ability to create and execute programs that improved patient experience and impacted sales as US lead for ERBITUXExhibited strategic and tactical excellence as US brand leader for ReoPro resulting in sales increases after a multi-year declineRiva trained moderator who has conducted 100s of individual consultations, focus groups and scientific panels. Identified, initiated and established relationships with Thought Leaders in multiple areasClinical pharmacist with university medical center, hospital and community pharmacy experienceMember of ASCO, APhA, ASHP